littl
known
immunopathogenesi
chikungunya
viru
circul
level
immun
mediat
growth
factor
analyz
patient
infect
first
singaporean
chikungunya
fever
outbreak
earli
establish
biomark
associ
infect
andor
diseas
sever
adult
patient
laboratoryconfirm
chikungunya
fever
infect
refer
communic
diseas
centretan
tock
seng
hospit
period
januari
februari
includ
retrospect
studi
plasma
fraction
analyz
use
multiplexmicrobead
immunoassay
among
patient
common
clinic
featur
fever
arthralgia
rash
conjunct
profil
cytokin
chemokin
growth
factor
abl
discrimin
clinic
form
chikungunya
healthi
control
patient
classifi
nonsever
sever
diseas
level
plasma
cytokin
growth
factor
significantli
elev
statist
analysi
show
increas
decreas
rant
associ
diseas
sever
conclus
first
comprehens
report
product
cytokin
chemokin
growth
factor
acut
chikungunya
viru
infect
use
biomark
abl
distinguish
mild
diseas
sever
form
chikungunya
fever
thu
enabl
identif
patient
poor
prognosi
monitor
diseas
recent
year
emerg
reemerg
tropic
infecti
diseas
shown
caus
high
social
econom
impact
vectorborn
infecti
diseas
dengu
west
nile
resurg
larg
due
spread
insecticid
resist
sociodemograph
chang
genet
mutat
pathogen
recent
chikungungya
fever
chikf
emerg
next
import
infect
southeast
asia
pacif
region
europ
make
major
threat
requir
immedi
attent
recent
epidem
resurg
chikf
sever
african
asian
countri
demonstr
infect
spread
alarmingli
rapidli
limit
earli
transmiss
develop
unpreced
unexpect
epidem
infect
popul
occur
reunion
island
appear
case
europ
unit
state
countri
travel
return
known
outbreak
area
underscor
contributori
factor
increas
human
mobil
tourism
global
climat
chang
increas
insecticid
resist
era
global
threat
diseas
epidem
underestim
public
health
event
could
crippl
public
health
system
economi
chikungunya
viru
chikv
caus
chikf
alphaviru
togavirida
famili
linear
positivesens
singlestrand
rna
genom
contain
two
larg
open
read
frame
orf
first
encod
nonstructur
protein
encod
structur
protein
includ
capsid
protein
c
major
envelop
surfac
glycoprotein
small
protein
chikv
transmit
aed
mosquito
mainli
albopictu
aegypti
chikf
acut
ill
abrupt
fever
skin
rash
arthralgia
occasion
involv
nervou
system
heart
liver
prolong
incapacit
arthralgia
sometim
report
persist
year
concern
reemerg
chikv
caus
consider
morbid
fatal
wherea
previous
chikf
consid
rel
benign
despit
fact
clinic
featur
recent
acut
chikv
infect
sever
countri
describ
littl
known
longterm
sequela
pathogenesi
arthropathi
acquisit
protect
immun
remain
unexplor
propos
chikvinduc
arthriti
arthralgia
immunopatholog
origin
present
specif
effect
treatment
chikf
patient
manag
larg
symptomat
relief
primarili
antiinflammatori
drug
given
expand
geograph
rang
chikv
potenti
rapidli
caus
larg
scale
epidem
becom
import
understand
immun
pathogen
mechan
activ
chikv
infect
order
guid
develop
target
effect
control
treatment
strategi
cytokin
chemokin
thought
play
import
role
viral
immunopatholog
although
ifnc
implic
pathogenesi
chikf
global
analysi
specif
involv
diseas
sever
yet
defin
growth
factor
usual
produc
respons
injuri
viral
infect
chikv
induc
cellular
damag
may
lead
secret
factor
howev
limit
studi
conduct
studi
took
opportun
conduct
detail
studi
patient
first
outbreak
chikf
singapor
measur
circul
level
wide
rang
cytokin
chemokin
growth
factor
laboratori
confirm
case
chikf
compar
healthi
individu
next
determin
biomark
associ
infect
andor
sever
show
first
time
chikv
infect
induc
wide
rang
cytokin
chemokin
growth
factor
subsequ
found
specif
biomark
name
rant
level
associ
sever
chikf
patient
includ
studi
male
age
rang
year
median
year
except
one
foreign
nation
half
patient
classifi
sever
chikf
defin
sever
chikf
temperatur
puls
rate
platelet
count
g
l
base
studi
defin
sever
diseas
except
singapor
resid
none
preexist
medic
condit
despit
previous
healthi
four
nonresid
develop
sever
ill
fever
last
day
fever
durat
significantli
differ
sever
ill
mean
day
vs
mean
day
two
patient
report
persist
arthralgia
last
two
week
demograph
clinic
detail
chikf
patient
summar
tabl
among
patient
common
clinic
featur
fever
arthralgia
rash
conjunct
tabl
gastrointestin
constitut
symptom
less
promin
arthriti
observ
one
patient
effus
right
knee
none
neurolog
involv
hemorrhag
manifest
tabl
present
summari
key
laboratori
find
among
patient
throughout
cours
ill
white
cell
count
hemoglobin
hematocrit
platelet
count
erythrocyt
sediment
rate
patient
within
normal
rang
mean
nadir
platelet
count
l
one
patient
sever
thrombocytopenia
nadir
platelet
count
l
cours
ill
elev
creactiv
protein
level
crp
mgl
observ
patient
peak
creactiv
protein
level
significantli
differ
classifi
sever
ill
mean
mgl
vs
mean
mgl
p
mean
peak
alanin
aspart
transaminas
alt
ast
ul
ul
respect
alt
ast
greater
upper
limit
normal
one
patient
preexist
liver
cirrhosi
none
patient
clinic
abnorm
total
protein
urea
creatinin
level
among
patient
mean
nadir
protein
level
gdl
mean
peak
urea
creatinin
level
mmoll
mmoll
respect
lactat
dehydrogenas
level
laboratori
paramet
significantli
higher
sever
ill
patient
compar
mean
ul
vs
mean
ul
p
profil
cytokin
chemokin
growth
factor
determin
multiplexmicrobead
immunoassay
acut
blood
sampl
collect
upon
hospit
sampl
collect
rang
day
day
ill
median
day
character
overal
pattern
twoway
hierarch
cluster
analysi
done
allow
classif
individu
accord
diseas
sever
base
clinic
featur
figur
evid
power
discrimin
clinic
form
chikf
sampl
studi
healthi
control
patient
classifi
nonsever
sever
diseas
segreg
perfectli
level
plasma
cytokin
ifna
observ
significantli
elev
figur
chikf
patient
compar
uninfect
subject
among
proinflammatori
cytokin
signific
interestingli
anoth
proinflammatori
cytokin
downregul
patient
antiinflammatori
cytokin
found
significantli
rais
patient
plasma
concentr
found
increas
patient
level
ifna
elev
patient
level
cytokin
ifnc
tnfa
margin
increas
chikf
group
compar
uninfect
group
figur
profil
chemokin
mig
shown
significantli
elev
eotaxin
suppress
figur
differ
level
chemokin
name
rant
figur
interestingli
level
growth
factor
found
signific
patient
upregul
hgf
fgfbasic
vegf
except
egf
almost
total
suppress
figur
observ
chikf
patient
exhibit
low
level
gmcsf
gcsf
figur
final
effort
identifi
cytokin
chemokin
growth
factor
plasmat
level
associ
sever
statist
analys
perform
stratif
chikf
patient
accord
sever
observ
increas
level
decreas
rant
respect
associ
diseas
sever
figur
level
marker
significantli
differ
figur
chikf
emerg
arbovir
infect
induc
high
fever
recent
report
singapor
dec
chikf
patient
contract
infect
oversea
first
local
outbreak
chikf
occur
jan
peopl
live
work
outbreak
area
screen
total
pcrconfirm
case
identifi
confirm
chikf
case
refer
cdcttsh
report
includ
patient
particip
studi
phylogenet
analysi
viral
sequenc
patient
reveal
circul
strain
indian
ocean
genotyp
close
relat
outbreak
india
without
mutat
emphas
remark
rapid
diseas
could
spread
right
environment
condit
attack
rate
outbreak
much
lower
report
reunion
island
observ
itali
could
attribut
rapid
remov
human
reservoir
isol
enhanc
vector
control
circul
viru
strain
lower
epidem
potenti
clinic
featur
patient
similar
report
recent
outbreak
indic
although
peopl
genet
divers
respons
diseas
homogen
across
peopl
nonhomogen
popul
major
patient
year
premorbid
condit
unlik
patient
report
reunion
island
outbreak
patient
underli
medic
condit
could
contribut
observ
morbid
patient
younger
healthier
furthermor
none
patient
coinfect
dengu
confirm
rtpcr
dengu
enzymelink
immunoabsorb
assay
elisa
igm
igg
henc
immunolog
observ
larg
attribut
acut
chikv
infect
recent
year
studi
chikf
address
clinic
descript
diseas
molecular
natur
viru
diagnost
method
interact
viru
mosquito
vector
aed
describ
first
time
comprehens
system
product
cytokin
chemokin
growth
factor
acut
chikv
infect
may
light
path
ahead
understand
innat
respons
infect
first
show
wide
rang
cytokin
ifna
produc
respons
chikv
infect
ifna
potent
antivir
cytokin
shown
strongli
inhibit
chikv
vitro
high
level
ifna
detect
provid
logic
explan
bodi
rapidli
bring
chikv
viremia
control
shown
main
produc
ifna
plasmocytoid
dendrit
cell
monocyt
profil
circul
cytokin
reveal
predomin
type
cytokin
mainli
level
increas
ifnc
tnfa
unchang
compar
noninfect
control
suggest
acut
chikv
infect
tilt
cytokin
profil
antiinflammatori
respons
would
argu
common
understand
chikv
infect
realli
support
common
descript
chikv
infect
inflammatori
diseas
altern
possibl
inflammatori
respons
might
occur
earlier
viru
activ
replic
get
downregul
counterantiinflammatori
respons
viru
elimin
circul
high
level
antiinflammatori
presenc
high
level
chemokin
mig
ligand
associ
reaction
detect
would
support
hypothesi
studi
would
need
clarifi
issu
type
cytokin
detect
also
import
mediat
b
cell
growth
matur
thu
may
allow
product
high
level
persist
antichikv
igg
detect
high
level
circul
interest
sinc
cytokin
shown
major
stimul
nk
cell
cell
thu
data
suggest
lymphocyt
popul
might
activ
acut
infect
may
also
contribut
viral
control
acut
phase
chikv
infect
detect
solubl
plasma
suggest
cell
activ
sinc
molecul
secret
activ
cell
experi
plan
studi
activ
phenotyp
nk
cell
subset
acut
infect
patient
detect
significantli
interest
regard
immunopatholog
chikf
sinc
chikv
infect
shown
induc
rapidli
develop
persist
arthralgia
patient
manifest
patholog
known
import
role
develop
rheumatoid
arthriti
associ
develop
joint
inflamm
propos
expans
particular
nk
cell
subset
respons
phenomenon
role
nk
cell
develop
chikv
arthralgia
would
definit
worth
investig
detect
tnfa
plasma
patient
acut
chikv
infect
surpris
sinc
cytokin
detect
repeatedli
blood
patient
suffer
arthritid
rheumatoid
arthriti
known
involv
pathogenesi
entiti
thu
possibl
chikvinduc
arthralgia
depend
tnfa
altern
tnfa
might
produc
local
analysi
synovi
fluid
joint
tissu
immunohistochemistri
would
necessari
provid
import
inform
role
tnfa
mediat
chemokin
crucial
mediat
innat
adapt
immun
variou
viral
infect
mig
increas
plasma
level
chikv
infect
two
chemokin
signal
receptor
thu
might
activ
direct
migrat
cell
subset
eotaxin
level
lower
naiv
control
defin
exact
contribut
differ
chemokin
requir
studi
also
test
presenc
growth
factor
plasma
chikvinfect
patient
hgf
fgfbasic
vegf
produc
high
level
may
reflect
physiolog
respons
tissu
destruct
result
viral
infect
interestingli
egf
level
lower
healthi
control
low
level
egf
might
due
concomit
decreas
platelet
observ
infect
patient
sinc
previou
studi
shown
plasma
level
egf
associ
circul
platelet
although
limit
access
suffici
patient
perform
data
analysi
relat
sever
diseas
sever
ill
defin
fever
maximum
puls
rate
beatsminut
nadir
platelet
count
l
use
definit
observ
higher
diseas
sever
associ
increas
plasma
level
decreas
level
rant
figur
whose
level
alreadi
high
chikv
infect
patient
potent
endogen
pyrogen
therefor
elev
might
account
high
fever
sever
case
increas
product
might
also
mediat
develop
abrupt
persist
arthralgia
sinc
cytokin
involv
immunopathogenesi
mani
arthrit
patholog
rheumatoid
arthriti
contrari
cell
chemokin
rant
level
significantli
suppress
sever
chikf
patient
platelet
major
reservoir
rant
peripher
circul
sever
chikf
character
thrombocytopenia
thu
mention
egf
thrombocytopenia
also
reduc
level
circul
rant
low
level
rant
correl
diseas
sever
mortal
individu
sever
malaria
also
correspondingli
thrombocytopen
interestingli
observ
studi
rant
level
upregul
dengu
except
one
singl
report
cuba
sinc
symptom
chikf
mimic
dengu
fever
result
obtain
studi
strongli
suggest
rant
could
potenti
biomark
differenti
clinic
similar
diseas
one
limit
studi
classif
diseas
sever
none
patient
develop
neurolog
hemorrhag
complic
previous
report
chikf
patient
nonetheless
definit
sever
ill
would
includ
patient
sepsi
seriou
form
infect
commonli
associ
temperatur
heart
rate
minut
furthermor
includ
thrombocytopenia
l
criteria
sever
chikf
mark
thrombocytopenia
common
featur
sepsi
identifi
predictor
mortal
degre
thrombocytopenia
determin
surviv
platelet
count
decreas
l
mortal
continu
increas
even
though
risk
bleed
wide
spectrum
diseas
report
chikf
rang
asymptomat
infect
selflimit
febril
ill
neurolog
complic
death
sever
ill
cohort
studi
possibl
repres
sever
form
selflimit
febril
ill
intermedi
group
higher
level
viremia
data
shown
distinctli
sever
clinic
featur
ie
high
temperatur
tachycardia
sever
thrombocytopenia
use
clinic
phenotyp
shown
studi
immun
mediat
abl
distinguish
mild
diseas
sever
form
chikf
diseas
acut
stage
followup
studi
requir
determin
longterm
sequela
inde
differ
nonsever
sever
clinic
present
elucid
associ
diseas
sever
two
cytokin
one
chemokin
use
order
provid
earli
identif
monitor
patient
sever
diseas
although
studi
limit
size
outbreak
nevertheless
base
observ
measur
immun
mediat
could
help
manag
futur
outbreak
studi
strongli
suggest
biomark
use
measur
diseas
sever
test
outbreak
differ
popul
differ
strain
confirm
use
followup
studi
associ
studi
prognosi
public
health
manag
importantli
biomark
potenti
lead
develop
modul
reduc
diseas
sever
halt
diseas
progress
ten
patient
present
acut
chikf
communic
diseas
centr
tan
tock
seng
hospit
cdcttsh
nation
infecti
diseas
referr
centr
singapor
outbreak
period
januari
februari
includ
studi
acut
case
chikf
defin
case
clinic
featur
consist
chikf
chikv
infect
confirm
either
revers
transcriptionpolymeras
chain
reaction
rtpcr
viru
isol
studi
approv
institut
domainspecif
ethic
review
board
dsrb
refer
written
consent
obtain
patient
healthi
control
subject
plasma
sampl
obtain
patient
acut
phase
ill
data
demograph
characterist
premorbid
condit
clinic
featur
routin
hematolog
biochem
laboratori
test
find
ie
full
blood
count
renal
liver
function
test
creactiv
protein
also
collect
symptomat
patient
isol
cdcttsh
febril
ill
resolv
neg
chikv
rtpcr
test
obtain
hospit
stay
daili
monitor
bodi
temperatur
vital
paramet
blood
count
carri
patient
defin
sever
ill
either
maximum
temperatur
maximum
puls
rate
beatsminut
nadir
platelet
count
less
l
laboratori
result
express
addit
plasma
serum
sampl
healthi
volunt
febril
ill
preced
week
epidemiologicallylink
outbreak
also
includ
control
studi
plasma
sampl
collect
describ
aliquot
store
analys
done
multiplex
biometr
immunoassay
contain
fluoresc
dy
microspher
conjug
monoclon
antibodi
specif
target
protein
use
cytokin
measur
accord
manufactur
instruct
biosourc
human
cytokin
assay
invitrogen
follow
group
cytokin
inflammatori
gmcsf
tnfalpha
ifngamma
cytokin
ii
ifnalpha
chemokin
eotaxin
mig
rant
growth
factor
egf
hgf
fgfbasic
gcsf
vegf
briefli
ul
plasma
sampl
dilut
incub
antibodi
coupl
bead
h
rt
uc
complex
wash
twice
use
vacuum
manifold
incub
biotinyl
detector
antibodi
h
rt
uc
complex
wash
twice
follow
incub
streptavidinphycoeryrhrin
rpe
min
rt
uc
complex
wash
thrice
incub
wash
buffer
anoth
min
detect
luminex
tm
instrument
result
acquir
softwar
standard
curv
plot
fiveparamet
logist
curv
set
compar
analyz
express
profil
across
result
raw
cytokin
valu
normal
use
zscore
convers
base
formula
x
raw
valu
convert
mean
popul
standard
deviat
sd
popul
transform
valu
denot
z
exhibit
posit
valu
raw
valu
mean
vice
versa
examin
nuanc
correl
mask
full
set
data
z
valu
subject
cluster
analysi
yield
order
numofrowsx
numofcol
express
level
matrix
e
el
hierarch
cluster
appli
column
repres
myriad
cytokin
level
measur
eg
base
mcquitti
wpgma
method
distanc
pair
group
b
measur
use
weight
arithmet
mean
pairwis
distanc
data
point
b
row
repres
suspect
chikf
patient
healthi
individu
left
untouch
seriat
perform
follow
cluster
approach
reorder
cluster
data
point
use
minimum
path
length
algorithm
minim
sum
distanc
adjac
column
euclidean
distanc
use
cluster
seriat
phase
measur
differ
dissimilar
data
point
x
x
given
equat
dffi
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
comparison
group
calcul
mannwhitney
rank
sum
statist
analys
done
kruskalw
test
follow
dunn
multipl
comparison
test
p
valu
consid
statist
signific
figur
complet
profil
level
pgml
cytokin
chemokin
growth
factor
determin
multiplexbead
array
blood
sampl
collect
chikvinfect
patient
healthi
control
subject
